Disease progression in relation to age at onset in a population with Alzheimer’s Dementia
- 28 August 2018
- journal article
- research article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 31 (5) , 723-725
Abstract
One thousand and 679 Alzheimer’s Disease patients (early onset EO: 152 and late onset LO: 1527) were evaluated after 12, 36 and 60 months. At baseline EO patients have higher Mini Mental State examination (MMSE) and fewer comorbidities in respect to LO group. The MMSE score did not significantly differ after 12, 36 and 60 months; a more marked worsening in instrumental daily activities was observed after 36 months in the EO compared with the LO group. These data allow to conclude that EO patients may have a slight faster progression in the disease within the first 3 years after the diagnosis, but in a longer follow-up no differences exist in respect to LO group. The literature failed to identify specific factors capable to influence the disease progression in AD. Our data are in substantial agreement with the literature and seem to confirm the great heterogeneity of AD patients.Keywords
This publication has 6 references indexed in Scilit:
- The vascular facet of late-onset Alzheimer's disease: an essential factor in a complex multifactorial disorderCurrent Opinion in Neurology, 2017
- Early- versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 yearsAlzheimer's Research & Therapy, 2017
- Correlations among age, cognitive impairment, and comorbidities in Alzheimer’s disease: report from a center for cognitive disordersAging Clinical and Experimental Research, 2017
- Early-Onset Alzheimer DiseaseNeurologic Clinics, 2017
- The Progression of Alzheimer’s Disease: Are Fast Decliners Really Fast? A Four-Year Follow-UpJournal of Alzheimer’s Disease, 2017
- Differences in Routine Clinical Practice between Early and Late Onset Alzheimer's Disease: Data from the Swedish Dementia Registry (SveDem)Journal of Alzheimer’s Disease, 2014